Evermay Wealth Management’s GSK GSK Stock Holding History

Evermay Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58K	Buy	1,102 +904	+457%	+$47.8K	0.01%	338
2026 Q1	$11K	Hold	198	–	–	﹤0.01%	454
2025 Q4	$9.8K	Hold	198	–	–	﹤0.01%	449
2025 Q3	$8.63K	Hold	198	–	–	﹤0.01%	455
2025 Q2	$7.69K	Hold	198	–	–	﹤0.01%	460
2025 Q1	$7.75K	Hold	198	–	–	﹤0.01%	465
2024 Q4	$6.77K	Hold	198	–	–	﹤0.01%	474
2024 Q3	$8.17K	Hold	198	–	–	﹤0.01%	473
2024 Q2	$7.7K	Hold	198	–	–	﹤0.01%	475
2024 Q1	$8.57K	Hold	198	–	–	﹤0.01%	483
2023 Q4	$7.41K	Hold	198	–	–	﹤0.01%	468
2023 Q3	$7.25K	Hold	198	–	–	﹤0.01%	454
2023 Q2	$7.13K	Hold	198	–	–	﹤0.01%	448
2023 Q1	$7.11K	Hold	198	–	–	﹤0.01%	441
2022 Q4	$7.02K	Hold	198	–	–	﹤0.01%	442
2022 Q3	$6K	Hold	198	–	–	﹤0.01%	437
2022 Q2	$11K	Hold	198	–	–	﹤0.01%	385
2022 Q1	$11K	Hold	198	–	–	﹤0.01%	412
2021 Q4	$11K	Hold	198	–	–	﹤0.01%	400
2021 Q3	$9K	Sell	198 -320	-62%	-$16.1K	﹤0.01%	390
2021 Q2	$26K	Buy	+518	New	+$24.9K	﹤0.01%	337

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Evermay Wealth Management's GSK Position: Q2 2026 in Review

Evermay Wealth Management increased its GSK (GSK) stake by 457% in Q2 2026, buying an estimated $47.8K and bringing the position to 1,102 shares worth $58K. The position accounts for 0.01% of the portfolio, ranked #338.

Evermay Wealth Management first reported a position in GSK in Q2 2021 and has held it in 21 quarters since. 1,041 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Evermay Wealth Management held 1,102 shares of GSK worth $58K as of Q2 2026.
Evermay Wealth Management bought 904 GSK shares in Q2 2026, an estimated $47.8K.
GSK made up 0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #338 holding.
Evermay Wealth Management first reported a position in GSK in Q2 2021 and has held it in 21 quarters since.
1,041 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.